awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38368008-6D5463C6-FA52-4F05-8E0E-67430603505C
Q38368008-6D5463C6-FA52-4F05-8E0E-67430603505C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38368008-6D5463C6-FA52-4F05-8E0E-67430603505C
Sorafenib: a review of its use in patients with radioactive iodine-refractory, metastatic differentiated thyroid carcinoma.
P2860
Q38368008-6D5463C6-FA52-4F05-8E0E-67430603505C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38368008-6D5463C6-FA52-4F05-8E0E-67430603505C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
980c94fe438112c96e8a0d54eb179ec4d02b5c79
P2860
Rationale and design of decision: a double-blind, randomized, placebo-controlled phase III trial evaluating the efficacy and safety of sorafenib in patients with locally advanced or metastatic radioactive iodine (RAI)-refractory, differentiated thyr